Indian pipe

Synopsis

Indian Pipe (Monotropa uniflora): A Comprehensive Reference

1. Identity: Botanical Name, Source, and Common Forms

Botanical Identity and Taxonomy

Monotropa uniflora, also known as the American Indian ghost pipe plant (shortened to ghost plant, ghost pipe, American Indian pipe, or Indian pipe), is a herbaceous, parasitic, non-photosynthesizing, perennial flowering plant native to temperate regions of Asia, North America, and northern South America, but with large gaps between areas. The Indian Pipe was originally classified into the family Monotropaceae, but after further research was reclassified to be included in the Ericaceae family of plants (heaths). The combination Monotropa uniflora was published by Linnaeus in his monumental work, Species Plantarum, in 1753.

The name "Monotropa" is Greek for "one turn" and "uniflora" is Latin for "one flowered," as there is one sharply curved stem for each single flower. Among English-speaking populations in North America, Monotropa uniflora has also been known as "Indian pipe," "convulsion root," "ice plant," and "ghost pipe." Indian Pipe derives its common name from its supposed resemblance, when in flower, to a peace pipe. Other common names include Indianpipe, Indian-pipe, One-flower Indian Pipe, Ghost Plant, Corpse Plant, Ghost Pipe, and Ghost Flower. The latter names are a reference to the plant's waxy, ghostly appearance.

Physical Description

This plant has a dark-colored, fibrous, perennial root, matted in masses about as large as a chestnut-burr, from which arise one or more short, ivory-white stems, 4 to 8 inches high, furnished with sessile, lanceolate, white, semi-transparent, approximate leaves or bracts, and bearing a large, white, terminal, solitary flower, which is at first nodding, but becomes upright in fruit. The plant is waxy white, but some specimens have been described as having black flecks or pale pink coloration. Rare variants may have a deep red color. The plant turns black as the fruit ripens or when it is picked and dried.

Ecological Character and Mycoheterotrophic Biology

Monotropa uniflora is achlorophyllous and is mycoheterotrophic; that is, it utilizes fungi to obtain carbon from the roots of autotrophic plants. Instead of fixing carbon through photosynthesis, ghost pipe forms connections with mycorrhizal fungi in the soil and acquires carbon and other nutrients from its host. A plant that obtains its nutrition in this manner is termed a mycoheterotroph. Like most mycoheterotrophic plants, M. uniflora associates with a small range of fungal hosts, all of them members of Russulaceae. It is often associated with beech trees.

It is of ephemeral occurrence, depending on the right conditions (moisture after a dry period) to appear full grown within a couple of days. Ghost pipe is also known to enter prolonged periods of dormancy lasting up to several years. This makes it difficult to monitor stands over a long period of time. The reasons for these dormancy periods are unknown.

Geographic Range

In North America north of Mexico, Ghost Pipes occur from Nova Scotia to British Columbia, south to northernmost California in the west, and from Minnesota to eastern Texas and Florida in the east. A disjunct population occurs in cool mountainous regions of southern Mexico, and through Central America to Colombia. Ghost Pipes are also found widely in southern and eastern Asia. This plant occurs mostly in the eastern USA and Pacific Northwest but also in Mexico and parts of Asia. It occurs in a variety of coniferous, deciduous or mixed forests that vary from wet to dry and in extent from sea level to 3,000 m, and often grows in acidic soil conditions in cool moist habitats.

Common Preparations and Forms

Root has been used medicinally by the Cherokee, Mohegan, and Potawatomi. Flower use by the Cree, leaves by the Mohegan, and stems by the Thompson Indigenous groups. This ecological relationship makes Monotropa uniflora difficult to cultivate, and horticultural methods are not yet available. Today, all plant material appears to be entirely wild harvested. Contemporary commercial preparations are predominantly alcohol-based tinctures of the fresh whole plant or aerial parts. Because of its mycotrophic/mycoparasitic nature, Monotropa uniflora is difficult to impossible to cultivate in a garden setting. The plants require well-established networks that fungi form with forest trees, the human management of which is beyond the realm of contemporary horticulture. Nursery propagated plants are not available.

2. Traditional and Historical Use

Indigenous North American Use

In North America, Monotropa uniflora has been used by the Cherokee, Cree, Mohegan, Potawatomi, and Thompson (Nlaka'pamux) Indigenous peoples for conditions ranging from epileptic convulsions to fevers to skin sores.

Recorded tribal uses include:

The Cherokee reportedly used pulverized roots as an anticonvulsive, and it was given to children experiencing fits or convulsions. The Cherokee also used the crushed plant on bunions and warts, and the juice of the plant was mixed with water as a wash for sore eyes.
The Mohegan used an infusion of the plant and/or its roots for colds and fevers, including as an analgesic for pain associated with fevers.
The Cree used to chew the flowers for toothaches.
The Thompson frequently used the crushed plant, burned stalk, or its dried and powdered form as a dermatological aid. It was particularly used for sores and wounds that were stubborn to heal.
The plant was used by some native North American Indian tribes to treat eye problems; the stem was bruised and the clear fluid of the stems applied to the eyes.

It was recognized as a beneficial medicine in pre-pharmaceutical days, as Native Americans and settlers used its sap to make a lotion to treat inflamed eyes, warts, and bunions and to make a poultice for sores. Its dried leaves and stems treated a variety of ailments, including fevers and cold symptoms, and its dried roots pounded into powder for tea treated pain, convulsions, muscle spasms, epileptic fits, insomnia, nervousness, and agitation.

Eclectic Medical Use (19th Century)

Ghost pipe first became popular as a medicinal plant in the United States in the mid-nineteenth century, primarily due to its use by Eclectic medical practitioners. The Eclectics rejected "injurious" practices such as bloodletting, purging, and treatments with mercury, and instead emphasized developing a distinct pharmacopoeia based on Indigenous plant remedies, which was deemed as "the safest way of treating disease." Ghost pipe was included in the practice of many Eclectic physicians as a tonic, sedative, nervine, antispasmodic, and ophthalmic.

Ghost pipe is described in King's American Dispensatory as a remedy for convulsions, anxiety, and pain. The origins of this entry are an 1881 case report detailing the use of 5 drops to treat convulsions in a pregnant woman. No other clinical or treatment details are available, and the original author is unknown. Felter and Lloyd, in the 1898 King's American Dispensatory, specify periodic fevers, childhood (febrile) seizures, epileptic seizures, ophthalmic inflammation, and bladder inflammation as indications.

In the 19th century, Eclectic physicians in the United States adopted ghost pipe as a sedative, tonic, and analgesic, considering it an alternative to opium for pain relief. However, ghost pipe eventually disappeared from medical literature as eclectic medicine slowly declined under increasing pressure to standardize from the American Medical Society and the closure of the flagship Eclectic Medical Institute in 1939. This disappearance also resulted in a decline in interest and scientific documentation of ghost pipe after this time.

Use in Asian Traditional Medicine

In China, it is known as shuǐ jīng lán (水晶兰), which translates to "crystal orchid." A decoction of the stems and/or roots is listed primarily as a respiratory agent to "replenish deficiency in the lungs" and relieve cough. Monotropa uniflora also appears in several herbals from India as a sedative, antispasmodic, and nervine, but it is unclear if these applications are derived from diffusion of western herbal practices or endemic herbal traditions.

20th-Century Revival

The resurgence of herbal medicine in the U.S. during the 1960s and 1970s led to the revival of eclectic medicine, and subsequently the rediscovery of ghost pipe as a medicinal plant by herbalists. For example, in the late 1970s, clinical herbalist David Winston began using a tincture (i.e., alcohol extract) of ghost pipe in combination with other herbal tinctures to treat patients with severe chronic pain. However, public awareness and popularity of ghost pipe would not begin until the early 2000s, when the introduction of the internet as a platform for herbalism coincided with an expansion in the medicinal applications of ghost pipe. For example, in 2005, herbalist Ryan Drum posted a blog article reaffirming ghost pipe's ability to relieve pain and hypothesizing the potential for ghost pipe to help with psychiatric nervous symptoms as well as motor/spasmodic symptoms.

Contemporary Folk Use

In findings recently published in Economic Botany, researchers reported the results of a digital survey conducted within the United States asking participants whether they had foraged, consumed, or prescribed ghost pipe. Results showed that social media and the internet were the primary source of information and learning for respondents. Notably, respondents overwhelmingly reported consuming ghost pipe in tincture form and for pain management. Both findings appear to be recent developments, as there is limited indication from the historical record that ghost pipe was prepared and used in these ways.

3. Key Constituents and Putative Active Compounds

The chemical composition of ghost pipe is not yet fully characterized, which presents a fascinating area for ongoing research in both botany and pharmacology. The following compounds have been identified or hypothesized in the scientific and ethnobotanical literature, though comprehensive peer-reviewed phytochemical profiling remains sparse.

Glycosides and Salicylates

The plant contains glycosides and may be toxic to humans. In addition to various reported traditional medicine uses, the plant has been used as an analgesic and anxiolytic in herbal medicine since the late 19th century. This may be due to the plant containing salicylic acid and grayanotoxins. Among described pharmacological activities, the analgesic property has been attributed to the presence of salicylic acid, contributing to its pain-relieving effects.

Grayanotoxins: A Resolved Controversy

Ghost pipe is a North American traditional medicinal plant which has recently seen an increase in consumption nationwide. However, a single 1889 study reported the presence of grayanotoxin I in M. uniflora, generating controversy regarding its safety. It is essential to revisit this claim of toxicity given Monotropa uniflora's resurgence in popularity. Researchers applied more sensitive analytical techniques to determine the possible presence of grayanotoxins in a diverse sampling of M. uniflora, using mass spectrometry and MS2-based molecular networking. Across 50 M. uniflora samples, neither grayanotoxins nor structural analogues were detected, refuting the earlier analysis. This 2025 study, published in the Journal of Natural Products (Anez, Flail, Burkhart, and Kellogg), represents the most rigorous phytochemical investigation to date and substantially changes the toxicological picture for this plant.

Separately, the phytochemistry and bioactivity of ghost pipe has not been confirmed. One of the first and only published papers on ghost pipe phytochemistry suggested the presence of acutely toxic compounds (e.g., grayanotoxin) in the plant (Lasche 1889), but these results have not been verified in ghost pipe in the intervening period.

Arbutin and Hydroquinone Derivatives

Credible phytochemical analyses highlight compounds like monotropin, arbutin, and hydroquinone derivatives reported from Monotropa uniflora. Arbutin, also found in bearberry, exhibits urinary antiseptic properties, supporting traditional uses for bladder discomfort. Hydroquinone derivatives are associated with antioxidant activities and may scavenge free radicals. It should be noted that these attributions currently rest on limited published primary research specific to M. uniflora, and their presence and concentrations in the plant have not been rigorously validated in the peer-reviewed literature.

Phenolic Acids

Phenolic acids, such as caffeic acid, have been attributed with anti-inflammatory effects through COX enzyme inhibition, though again this attribution requires confirmation through plant-specific analytical studies. Unlike green plants, M. uniflora's parasitic nature entails siphoning nutrients from fungal networks entangled with host trees — a biochemical relationship that influences its phytochemical profile.

Summary of Phytochemical Status

Research is therefore needed to develop and examine best foraging stewardship practices, as well as horticultural practices that can be used to reliably propagate the species. This research should be complemented by studies of phytochemistry and bioactivity to examine possible therapeutic benefits as well as any safety risks. In short, the phytochemistry of M. uniflora is one of the least-studied aspects of this plant; the constituent claims circulating in popular herbal literature substantially outpace what has been rigorously validated through peer-reviewed analytical chemistry.

4. Scientific Evidence by Area of Use

Overall evidence level: Very weak. There are no published randomized controlled trials (RCTs), no systematic reviews, and no pharmacokinetic or clinical pharmacology studies of Monotropa uniflora in humans. Monotropa uniflora holds significant medicinal value, particularly for neurological and pain-related conditions. While traditional and anecdotal evidence supports its use, further scientific research is needed to fully understand its pharmacodynamics and potential applications. The evidence base consists almost entirely of ethnobotanical documentation, historical case reports, and in vitro or animal studies — primarily reported in secondary or non-peer-reviewed sources.

4a. Pain (Analgesic Use)

Respondents in the first scientific survey of U.S. ghost pipe users overwhelmingly reported consuming ghost pipe in tincture form and for pain management. Both findings appear to be recent developments, as there is limited indication from the historical record that ghost pipe was primarily prepared and used in these ways. The proposed mechanism involves salicylate compounds. The plant has been used as an anxiolytic in herbal medicine since the late 19th century. This may be due to the plant containing salicylic acid. No human clinical trials on analgesic effect have been published. The 2025 Penn State survey (Anez, Burkhart, Kellogg; published in Economic Botany) is the most rigorous documentation to date of contemporary use patterns, but documents reported use, not efficacy.

4b. Nervous System: Anxiolytic and Sedative Effects

An infusion of the root is described in historical sources as antispasmodic, hypnotic, nervine, and sedative. It is reported as a remedy for spasms, fainting spells, and various nervous conditions, and has been given to children who suffer from fits, epilepsy, and convulsions. The most specific historical clinical record is an 1881 published case report. This is an 1881 case report detailing the use of 5 drops to treat convulsions in a pregnant woman. No other clinical or treatment details are available, and the original author is unknown. No peer-reviewed human or animal studies specifically and verifiably examining anxiolytic or sedative endpoints have been published in indexed journals at the time of this writing.

4c. Antispasmodic and Anticonvulsant Use

Historical herbalism records describe it as a tonic and sedative used for convulsions in children, epilepsy, chorea, spasmodic affections, febrile diseases, as a diaphoretic, for restlessness, pains, nervous irritability, acute anxiety and/or psychotic episodes, severe mental and emotional pain, as well as intense nerve pain. This use is documented across multiple Indigenous traditions and in the 19th-century Eclectic pharmacopoeia. No controlled human or animal studies exist for these indications.

4d. Ophthalmic Use

The plant was used by some native North American Indian tribes to treat eye problems; the stem was bruised and the clear fluid of the stems applied to the eyes. The juice of the plant is used in traditional records to treat ophthalmic inflammation, general inflammation, ulcers, and gonorrhoea. No clinical investigation of this use has been published.

4e. Respiratory and Antipyretic Use

In China, a decoction of the stems and/or roots is listed primarily as a respiratory agent to "replenish deficiency in the lungs" and relieve cough. An infusion of the leaves has historically been used to treat colds and fevers. No clinical or preclinical studies for respiratory or antipyretic endpoints have been published.

4f. Antioxidant Activity

In vitro antioxidant activity has been reported but not in rigorously peer-reviewed publications focused on M. uniflora specifically. This remains an area where the available evidence is insufficient to draw meaningful conclusions about human benefit.

Summary of Evidence

"This study is the first to scientifically document use of ghost pipe in North America, along with the growing influence of social media and the internet on how and why people are turning to ghost pipe as a medicinal plant," noted team leader Eric Burkhart of Penn State in 2025. For all proposed uses, the evidence is currently limited to historical case reports, ethnobotanical surveys, and anecdotal user reports. No peer-reviewed randomized controlled trials, no systematic reviews, and no pharmacokinetic studies in humans have been published.

5. Body Systems and Health Areas Associated with Indian Pipe

Based on its documented traditional, ethnobotanical, and historical medical uses, Monotropa uniflora is associated with the following body systems and health areas:

Central and peripheral nervous system: Since the early nineteenth century, Monotropa uniflora has been used in herbal medicines as an anxiolytic to reduce anxiety. It is also used for psychosis, nervousness, irritability, restlessness, epilepsy, and convulsion episodes.
Musculoskeletal and pain pathways: The juice from the stems has also been used to treat nervous irritability, including fits and spasms. Contemporary tincture users predominantly report using the plant for pain management.
Dermatological: The crushed plant has been rubbed on bunions and warts in order to destroy them.
Ophthalmic: Application of the stem juice to the eyes for inflammation was recorded across multiple Indigenous traditions.
Respiratory: Use for coughs and lung conditions, particularly in traditional Chinese herbalism.
Urinary tract: The arbutin component of the plant is associated with mild diuretic and antiseptic properties.
Febrile/infectious: Historical use for periodic fevers and colds across multiple traditions.

6. Dosage Forms and Reported Dosages

Important caveat: No standardized dosages have been established in peer-reviewed clinical studies for any indication. The figures below are drawn solely from historical Eclectic sources and contemporary survey data, and are presented as documentation of reported practice, not as validated therapeutic doses.

Historical Eclectic Dosage Record

The earliest specific dosage found in the literature is an 1881 case report from the Eclectic Medical Journal detailing the use of 5 drops to treat convulsions in a pregnant woman. The 1898 King's American Dispensatory (Felter and Lloyd) records use of ghost pipe root preparations for convulsions, anxiety, and pain, though specific dosage ranges from this text are not consistently reproduced in available indexed sources.

Contemporary Reported Use

Survey respondents overwhelmingly reported consuming ghost pipe in tincture form and for pain management. Both findings appear to be recent developments, as there is limited indication from the historical record that ghost pipe was primarily prepared and used in these ways.

Two out of four respondents in the Penn State survey who reported negative effects indicated that this was due to "taking too much," suggesting that dose-dependent adverse effects have been anecdotally reported by contemporary users.

Preparation Methods

Historically documented preparation methods include: root infusions and decoctions; stem juice applied topically; and powdered dried root prepared as a tea or poultice. Some herbalists also prepare teas or infusions, though this is less common in contemporary practice, where alcohol tinctures predominate. The plant is typically tinctured fresh, as the plant turns black as the fruit ripens or when it is picked and dried.

7. Safety Considerations and Interactions

General Toxicological Status

Peterson's Field Guide to Medicinal Plants & Herbs lists some Native American uses for "Indian-Pipe" (Monotropa uniflora) then adds: "Safety undetermined; possibly toxic — contains several glycosides." Monotropa uniflora possesses low to moderate toxicity, attributed to its glycoside content, which can induce gastrointestinal distress, nausea, dizziness, and vomiting upon ingestion in humans.

Grayanotoxin Controversy — Resolved

A single 1889 study reported the presence of grayanotoxin I in M. uniflora, generating controversy regarding its safety. It is essential to revisit this claim of toxicity given Monotropa uniflora's resurgence in popularity. The most recent and methodologically robust study (Anez et al., 2025, Journal of Natural Products) applied targeted and untargeted mass spectrometry to 50 samples: using mass spectrometry and MS2-based molecular networking across 50 M. uniflora samples, neither grayanotoxins nor structural analogues were detected, refuting the earlier analysis. This substantially changes the toxicological risk profile relative to prior warnings, though the broader safety profile remains incompletely characterized.

Salicylate Content and Implications

Reported toxicological effects stem primarily from salicylate glycosides, similar to aspirin, causing irritation and upset stomach, though severe outcomes are uncommon. By analogy with other salicylate-containing plants, caution would be warranted in individuals with known salicylate sensitivity, aspirin allergy, bleeding disorders, or those taking anticoagulant medications, though no studies have specifically examined these interactions in the context of M. uniflora.

Heavy Metal Accumulation

The presence of deleterious grayanotoxins and the circumstance that some plants accumulate toxic levels of heavy metals argue against herbal medicinal use of Ghost Pipes, according to the Virginia Native Plant Society. The potential for heavy metal bioaccumulation from contaminated forest soils is a feature of several mycoheterotrophic plants and represents a plausible concern for wildcrafted specimens, though peer-reviewed analytical data specifically characterizing heavy metal levels in M. uniflora samples are lacking.

Dose-Dependent Adverse Effects

Human risks are primarily associated with misuse in herbal preparations, where overdose from tinctures may cause excessive sedation or deep sleep. The plant is potentially toxic to pets like cats and dogs due to salicylate content, which can cause gastrointestinal upset or more severe effects; no major documented cases exist but caution is advised.

Cultivability, Wildcrafting, and Conservation

Monotropa uniflora is challenging to cultivate due to its dependence on specific mycorrhizal fungi, making wild harvesting the primary source. Overharvesting poses a threat to its populations, leading to local depletion. Despite the claims from numerous blog posts about this plant, Monotropa uniflora is considered to have a globally "secure" conservation status (G5), meaning that it is not an endangered species. However, it is considered imperiled in some specific states such as Alaska, California, South Dakota, Nebraska, and Oklahoma. Its dependence on delicate soil ecology renders it vulnerable to anything affecting forests, such as droughts, fires, nitrogen runoff, timber harvests, and logging activities.

Absence of Regulatory Approval and Formal Monographs

As of the time of this writing, Monotropa uniflora does not appear in any WHO monograph, European Pharmacopoeia monograph, ESCOP monograph, German Commission E monograph, or NIH/NCCIH evidence review. It is not listed by any major regulatory body as an approved botanical drug or dietary supplement ingredient with established safety and efficacy profiles. Despite this recent popularity, there is no current literature documenting the medicinal uses, preparation practices, or economic trade for ghost pipe that meets the standards required for regulatory review.